Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Endovascular prosthesis

a technology for endovascular prosthesis and prosthesis, applied in the field of endovascular prosthesis, can solve the problems of high wall stress, aortic dissection or rupture, and significant problems of aortic diseases

Inactive Publication Date: 2004-05-20
ERBEL RAIMUND +3
View PDF6 Cites 51 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0083] Generally, the present prosthesis can be advantageously used to treat the indications of aortic disease referred to hereinabove. Specifically, as will be described in more detail hereinbelow, the present endovascular prosthesis has a longitudinal length which may be varied in vivo to optimize the length there while obviating or mitigated side branch occlusion.
[0091] The present endovascular prosthesis may be used advantageously to wrap the intimal flaps and thrombi to the aortic wall and thereby obviate or mitigate the danger of stroke and emboli without the need for anticoagulation. As the preferred form of the present prosthesis covers only a radial portion of the aortic circumference, blocking of side arteries, which are supplying the back bone, is obviated or mitigated. As the preferred form of the present prosthesis is open and not blocking the flow from the proximal and distal aorta during the implantation, a blood pressure increase is obviated or mitigated. Thus, a unique advantage of the present prosthesis is that it can be used even in multiple places of the aorta when more parts of the aorta are showing thrombus formation.

Problems solved by technology

Such wall weakening leads to higher wall stress, which can induce aortic dilatation and aneurysm formation, eventually resulting in aortic dissection or rupture.
Diseases of the aorta are a significant problem in medicine.
Drug treatment is used to lower blood pressure--this approach is disadvantageous since, at best, it modulates the effect of the disease while still leaving the patient at significant risk.
Surgery is disadvantageous due to the high mortality and morbidity, even in centers of excellence.
As stated above, despite surgeries mortality is still high.
The main problem is the organ perfusion of the abdomen which results in shock and multiorgan failure.
However, tears are not always found and non-communicating dissections are not uncommon.
The dissection can spread from diseased segments of the aortic wall in an antegrate or retrograde fashion, involving side branches and causing other complications.
Partial ruptures of the inner layer of the aorta allow the blood to enter the already damaged media and thus cause dissection of the aortic wall, eventually leading to a second lumen within the wall, to a rupture or healing during follow-up.
False aneurysms, aortic rupture or dissections may occur.
This has lead to a significant occurrence of stroke in patients.
Currently, there is no reliable treatment approach for aortic sclerosis particularly the Grade IV type.
Anticoagulation is a known approach, however this treatment must be accepted with the danger of hemorrhagic strokes, particularly in the older patients Further, the therapy is very difficult to monitor.
Surgery is very complicated and has a high mortality and morbidity.
Currently, surgery is not seen as a desirable alternative to anticoagulation therapy.
As a consequence of this blunt chest trauma, mediastinal hematoma can occur with abrupt death of the patient.
Even if surgery was timely performed, there is a significant mortality rate.
Most prior art attempts to improve surgical techniques to treat aortic dissection have not be particularly successful.
It is also worth pointing out that the so-call "stent grafts" are not well suited for treating diseases of the aorta.
This is inconvenient and requires inventory stocking of a number of stent grafts having a variety of different longitudinal lengths to have devices on hand for use in most situations.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Endovascular prosthesis
  • Endovascular prosthesis
  • Endovascular prosthesis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0102] Thus, with reference to FIG. 3, there is illustrated an expandable prosthesis 10 which comprises a plurality of annular members 12 which are joined to one another by one or more longitudinal spines 14. Annular members 12 are radially expandable. Further, spine 14 is longitudinally expandable.

[0103] Disposed over a portion of expandable prosthesis 10 is a cover material 16. Cover material 16 is adhered to various of annular members 12.

[0104] In the longitudinally retracted version of endovascular prosthesis 10 (i.e. FIG. 3a), the longitudinal length of cover material 16 is greater than the longitudinal length A of endovascular prosthesis 10 over which it is disposed. This can be achieved by a suitable means such as folding of cover material 10 and the like. Alternatively, cover materials 16 can be made of a material which can stretch.

[0105] As shown in FIG. 3b, it is possible to lengthen endovascular prosthesis 10 prior to radio expansion thereof. The manner by which this is a...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A endovascular prosthesis for implantation in a body passageway. The prosthesis comprises a tubular wall which is: (i) movable between a first longitudinal length and a second longitudinally length, and (ii) radially expandible for implantation of the prosthesis in the body passageway. In one embodiment, the tubular wall has a longitudinally length which is variable by an "accordian"-like action. In another embodiment, the tubular wall has a longitudinally length which is variable by an "telescoping"-like action. The longitudinal length of the tubular wall may be varied in vivo to optimize deployment of the endovascular prosthesis.

Description

[0001] In one of its aspects, the present invention relates to an endovascular prosthesis. In another of its aspects, the present invention relates to a method of treating an aortic disease condition in a patient.[0002] Stents are generally known. Indeed, the term "stent" has been used interchangeably with terms such as "intraluminal vascular graft" and "expandable prosthesis". As used throughout this specification the term "stent" is intended to have a broad meaning and encompasses any expandable prosthetic device for implantation in a body passageway (e.g., a lumen or artery).[0003] In the past ten years, the use of stents has attracted an increasing amount of attention due the potential of these devices to be used in certain cases, as an alternative to surgery. Generally, a stent is used to obtain and maintain the patency of the body passageway while maintaining the integrity of the passageway. As used in this specification, the term "body passageway" is intended to have a broad ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61F2/00A61F2/86A61F2/88
CPCA61F2/86A61F2/88A61F2250/0007A61F2002/075A61F2250/0024A61F2/958
Inventor ERBEL, RAIMUNDRICCI, DONALD RPENN, IAN MSHUKOV, GEORGE A
Owner ERBEL RAIMUND
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products